Researchers say drug improved survival among COVID-19 patients in 'major breakthrough'


An inexpensive drug looks to be able to improve survival odds for COVID-19 patients with "severe respiratory complications," according to a new study.
Researchers on Tuesday announced the results of a study in which 2,104 patients received dexamethasone, a steroid, and 4,321 patients received usual care, The Associated Press reports. The drug reduced deaths by one-third for patients who were on ventilators and one-fifth for patients who were receiving oxygen, they said.
However, the study didn't show a benefit to patients "who did not require respiratory support," according to the announcement.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"This is an extremely welcome result," University of Oxford's Peter Horby, one of the chief investigators on the study, said in a statement. "The survival benefit is clear and large in those patients who are sick enough to require oxygen treatment, so dexamethasone should now become standard of care in these patients. Dexamethasone is inexpensive, on the shelf, and can be used immediately to save lives worldwide."
Horby also described dexamethasone, which BBC News reports is "already used to reduce inflammation in a range of other conditions," as the "first drug to be shown to improve survival in COVID-19" and told Reuters this is a "major breakthrough." Still, Axios notes the results of this trial "have not been peer-reviewed, or published formally at all." The researchers said the details will be published "as soon as possible."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
5 explosively funny cartoons about the 4th of July
Cartoons Artists take on liberty and justice for all, a terrifying firework, and more
-
Jeff in Venice: a "triumph of tackiness"?
In the Spotlight Locals protest as Bezos uses the city as a 'private amusement park' for his wedding celebrations
-
Crossword: July 5, 2025
The Week's daily crossword puzzle
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia